Pharmacologic modulation of intracellular Na <sup>+</sup> concentration with ranolazine impacts inflammatory response in humans and mice
Max Lenz(Ludwig Boltzmann Institute for Digital Health and Prevention), Walter S. Speidl(University of Applied Sciences St Pölten), Manuel Salzmann(Medical University of Vienna), Johann Wojta(Medical University of Vienna), Andreja Rehberger Likozar(Ljubljana University Medical Centre), Laura Goederle(Medical University of Vienna), Michael J. M. Fischer(Medical University of Vienna), Philipp J. Hohensinner(Ludwig Boltzmann Institute for Age Research), Sabine Rauscher(Medical University of Vienna), Bruno K. Podesser(Ludwig Boltzmann Institute for Cardiovascular Research), Zoriza Krivaja(Medical University of Vienna), Christoph J. Binder(Medical University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Cosmin I. Ciotu(Medical University of Vienna), Miran Šebeštjen(University of Ljubljana), Konstantin A. Krychtiuk(Ludwig Boltzmann Institute for Cardiovascular Research), Christoph Kaun(University of Vienna), Christian Hengstenberg(Medical University of Vienna)
Cited by 8
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2020|1.5k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755